Clinical overview of linagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with Type 2 diabetes mellitus.

Science

First published in Expert Review of Endocrinology & Metabolism on 2013 Jan.
Expert Rev Endocrinol Metab. 2013 Jan;8(1):21-35. doi: 10.1586/eem.12.69.

Authors: Forst T, Pfützner A

Download full article as Pdf file:

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board

LET’S TALK SCIENCE

Martin Mulder

Senior Vice President Corporate & Business Development

LET’S TALK BUSINESS